Alexion is committed to the discovery, development and delivery of innovative therapies for patients with rare and life-threatening medical conditions. A global company with a European headquarters in Paris, we are proud to be helping establish the importance of Alexion’s work at a European level through clear and concise advocacy expertise.
Transforming lives through innovation
By providing concise, convincing and professional campaign material for Alexion, we are helping to ensure that there is now heightened awareness of rare diseases at a European level. A launch overview brochure entitled ‘Transforming lives through innovation’ was produced in 9 languages for the Europe Middle East & Africa region. The success of this piece now means that health authorities are beginning to better understand the implications of rare diseases and are making the needs of patients a priority in their agendas.